# A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients

> **NCT03344653** · NA · COMPLETED · sponsor: **Medtronic Vascular** · enrollment: 2000 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Medtronic Resolute Onyx Zotarolimus-Eluting Coronary Stent System
- **DEVICE:** Biosensors BioFreedom BA9 Drug Coated Coronary Stent

## Key facts

- **NCT ID:** NCT03344653
- **Lead sponsor:** Medtronic Vascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-02
- **Primary completion:** 2018-09-27
- **Final completion:** 2020-10-09
- **Target enrollment:** 2000 (ACTUAL)
- **Last updated:** 2020-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03344653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03344653, "A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03344653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*